Detalhe da pesquisa
1.
Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.
Nature
; 596(7872): 423-427, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34161961
2.
Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques.
J Virol
; 96(2): e0159921, 2022 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34705557
3.
Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaques.
NPJ Vaccines
; 7(1): 53, 2022 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35585080
4.
Prior infection with SARS-CoV-2 WA1/2020 partially protects rhesus macaques against reinfection with B.1.1.7 and B.1.351 variants.
Sci Transl Med
; 13(618): eabj2641, 2021 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34546094
5.
Immunity elicited by natural infection or Ad26.COV2.S vaccination protects hamsters against SARS-CoV-2 variants of concern.
Sci Transl Med
; 13(618): eabj3789, 2021 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34705477